Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay.

Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay.
J Virol Methods. 2020 Jul 10;:113925
Authors: Goldenberger D, Leuzinger K, Sogaard KK, Gosert R, Roloff T, Naegele K, Cuénod A, Mari A, Seth-Smith H, Rentsch K, Hinić V, Hirsch HH, Egli A
Abstract
The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses.
PMID: 32659240 [PubMed - as supplied by publisher]

Source: Journal of Virological Methods - July 9, 2020 Category: Virology Authors: Goldenberger D, Leuzinger K, Sogaard KK, Gosert R, Roloff T, Naegele K, Cuénod A, Mari A, Seth-Smith H, Rentsch K, Hinić V, Hirsch HH, Egli A Tags: J Virol Methods Source Type: research